Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.

Podobne zapisy

• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited
  od: Gautret, Philippe, i wsp.
  Wydane: (2021)
• Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes
  od: Gautret, Philippe, i wsp.
  Wydane: (2021)
• Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
  od: Gautret, Philippe, i wsp.
  Wydane: (2021)
• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
  od: Gautret, Philippe, i wsp.
  Wydane: (2020)
• Response to advances statistical methods and designs for clinical trials for COVID-19
  od: Gautret, Philippe, i wsp.
  Wydane: (2021)